Treatment for moderate to severe hidradenitis suppurativa
Part of Infections, Skin clinical trials.
This study tests a new medication called ORKA-002 to see if it can reduce the number of painful bumps and sores in people with moderate to severe hidradenitis suppurativa (a chronic skin condition). It may be an option for people who have not had success with antibiotic treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had hidradenitis suppurativa symptoms for at least 6 months
- Your bumps or sores are in at least 2 separate areas of your body, and at least one area is advanced (Hurley stage II or III)
- You have tried antibiotics for hidradenitis suppurativa and they didn't work well enough, or you had side effects, or you can't take them for medical reasons
- You do not have any other active skin conditions that would make it hard to evaluate your hidradenitis suppurativa
- You do not have any other autoimmune or inflammatory conditions besides hidradenitis suppurativa
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called SCT650C for people with moderate to severe hidradenitis suppurativa (HS). The goal is to see if it can reduce painful bumps and abscesses better than current treatments.
This study tests a drug called secukinumab (a type of biologic that targets inflammation) for people with moderate to severe hidradenitis suppurativa (HS). It may be an option if you have tried other treatments and they didn't work well.
This trial tests a new drug called NAV-240 for people with hidradenitis suppurativa (HS) who have not had success with antibiotics. The goal is to see if the drug can reduce the number of painful lumps and improve symptoms.
This trial is testing an experimental tablet called LT-002-158 in adults with moderate to severe hidradenitis suppurativa (HS) that hasn't improved enough with standard treatments. The goal is to see if it's safe and helps reduce painful lumps and abscesses.
This study tests a new injected medication (SPY072) for people with moderate to severe hidradenitis suppurativa (HS), a condition causing painful bumps and abscesses. The goal is to see if this treatment can reduce symptoms and improve quality of life.
This trial tests a new medication called CIT-013 for people with moderate to severe hidradenitis suppurativa (HS) who have not had enough relief from oral antibiotics. The goal is to see if this treatment can reduce painful bumps and abscesses.
Hear when a new Hidradenitis Suppurativa (HS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.